Last reviewed · How we verify

NCT04579341

Probiotics Supplementation Effect on Glucose Homeostasis in Children With Type 1 Diabetes

Status unknown NA Last updated 8 October 2020
What this trial tests

NA trial testing probiotics in Diabetes Mellitus, Type 1 in 70 participants. Status unknown.

Timeline
21 January 2018
Primary endpoint
28 October 2020
10 November 2020

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment70
Start date21 January 2018
Primary completion28 October 2020
Estimated completion10 November 2020
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 5 to 18, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Probiotics influence immune homeostasis, through altering gut microbiota. The efficacy of probiotics in diabetes has been shown in preclinical settings as well as in human trials. Interleukin (IL)-21 and IL22 have been implicated in the pathogenesis of T1D. Objectives: to assess the effect of oral supplementation with probiotics on glycemic control as well as IL-21 and IL-22 levels in children with T1D. Methods: This randomized-controlled trial study included 70 children with T1D. Enrolled children aged 5-18 years with disease duration \> 1 year. They were randomly assigned into two groups; intervention group (group A) who received oral probiotics containing Lactobacillus acidophilus La-14 (108 CFU) 0.5 mg once daily. The other group (group B) did not receive any supplementation and served as a control group. Both groups were followed-up for 6 months with assessment of fasting blood glucose (FBG), HbA1c, IL-21 and IL-22 levels.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Gut microbiota in the pathogenesis and therapeutic approaches of diabetes.
    Crudele L, Gadaleta RM, Cariello M, Moschetta A. · · 2023 · cited 147× · PMID 37804567 · DOI 10.1016/j.ebiom.2023.104821
  2. Probiotic Supplementation Improves Glucose Homeostasis and Modulates Interleukin (IL)-21 and IL-22 Levels in Pediatric Patients with Type 1 Diabetes: A Randomized Placebo-Controlled Trial.
    Adly AAM, Ismail EAR, Abd-Elgawad MM, Salah NY. · · 2025 · PMID 40422866 · DOI 10.3390/metabo15050288

Verify or expand the search:

Other trials of probiotics

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04579341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing